INOVIO (INO), the International Vaccine Institute, and Seoul National University Hospital have partnered to start a Phase 1/2 clinical trial of INOVIO's COVID-19 vaccine candidate INO-4800 in South Korea. This is the first COVID-19 vaccine clinical study approved in South Korea. It will be funded by the Coalition for Epidemic Preparedness Innovations through INOVIO, and supported by the Korea Center for Disease Control and Prevention/Korea National Institute of Health.
from RTT - Biotech https://ift.tt/3cDDfLO
via IFTTT
No comments:
Post a Comment